BELLUS announces Chief Financial Officer to depart effective May 22, 2009

    LAVAL, QC, April 24 /CNW Telbec/ - BELLUS Health announced today that
Vice President, Finance and Chief Financial Officer Mr. Mariano Rodriguez will
depart from the Company, effective May 22, 2009.
    "Mr. Rodriguez has been an important contributing member of the BELLUS
Health executive team during his tenure with us. His professionalism and
unwavering dedication have aided the development of the Company and, most
recently, his contributions and expertise to the restructuring and refinancing
have been invaluable to both the continuity of BELLUS Health and its many
stakeholders. The Company is actively pursuing the development and
commercialization of its products. We wish to take this opportunity to thank
Mr. Rodriguez for his support and wish him the best success in his future
endeavours," said Dr. Francesco Bellini, Chairman, President and Chief
Executive Officer.
    BELLUS Health intends to fill the vacant position on an interim basis
while a new senior financial executive is recruited.

    About BELLUS Health

    BELLUS Health is a global health company focused on the development and
commercialization of products to provide innovative health solutions to
address critical unmet needs.

    To Contact BELLUS Health

    For additional information on BELLUS Health and its drug development
programs, please call the Canada and United States toll-free number
1-877-680-4500 or visit the Web Site at

    Certain statements contained in this news release, other than statements
of fact that are independently verifiable at the date hereof, may constitute
forward-looking statements. Such statements, based as they are on the current
expectations of management, inherently involve numerous risks and
uncertainties, known and unknown, many of which are beyond BELLUS Health
Inc.'s control. Such risks include but are not limited to: the ability to
obtain financing immediately in the current markets, the impact of general
economic conditions, general conditions in the pharmaceutical and/or
nutraceutical industry, changes in the regulatory environment in the
jurisdictions in which the BELLUS Health Group does business, stock market
volatility, the availability and terms of any financing, fluctuations in
costs, and changes to the competitive environment due to consolidation, that
actual results may vary once the final and quality-controlled verification of
data and analyses has been completed, as well as other risks disclosed in
public filings of BELLUS Health Inc. Consequently, actual future results may
differ materially from the anticipated results expressed in the
forward-looking statements. The reader should not place undue reliance, if
any, on any forward-looking statements included in this news release. These
statements speak only as of the date made and BELLUS Health Inc. is under no
obligation and disavows any intention to update or revise such statements as a
result of any event, circumstances or otherwise, unless required by applicable
legislation or regulation. Please see the Annual Information Form of BELLUS
Health Inc. for further risk factors that might affect the BELLUS Health Group
and its business.

For further information:

For further information: Lise Hébert, Ph.D., (450) 680-4573,

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890